Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 9:58 p.m.

    🔍 Garfield Alastair (Executive)

    Company: RHYTHM PHARMACEUTICALS, INC. (RYTM)

    Report Date: 2026-08-13

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 7,763

    Detailed Transactions and Holdings:

    • Sold 2,007 shares of Common Stock at $116.1093 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,051.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,556 shares of Common Stock at $117.0759 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,495.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,400 shares of Common Stock at $118.2843 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,095.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 800 shares of Common Stock at $119.1688 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,295.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.
    • F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $115.67 to $116.62 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $116.72 to $117.66 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $117.73 to $118.71 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F5: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $118.73 to $119.52 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories